Abstract

The COVID-19 pandemic has brought a national and global vaccine race. This Article examines the race with respect to contemporary frameworks for biopharmaceutical research and development. Specifically, this Article focuses on the effect of patents, pre-production agreements, public-private partnerships, and vaccine misinformation. This Article analyzes lessons learned from the COVID-19 pandemic, advocates for promoting vaccine affordability and equity, and suggests modifications to existing preparedness frameworks to prepare for upcoming outbreaks of infectious disease.

ISSN

1533-4686

Keywords

Law, Covid, Covid-19, Coronavrus, Coronavirus Pandemic, Patent, Patents Intellectual Property, IP, Vaccine

Share

COinS